| NCT ID | NCT03062085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai High Myopia Study Group |
| Condition | High Myopia |
| Study Type | OBSERVATIONAL |
| Enrollment | 60,000 participants |
| Start Date | 2015-01-01 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60,000 participants in total. It began in 2015-01-01 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of cataract * Must be able to cooperate with the ophthalmic examination Exclusion Criteria: * Clinical diagnosis of mental illness * Mentally disabled
Contact & Investigator
Yi Lu, M.D.
STUDY CHAIR
Eye and ENT Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT03062085 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 100 Years, studying High Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03062085 currently recruiting?
Yes, NCT03062085 is actively recruiting participants. Contact the research team at luyieent@163.com for enrollment information.
Where is the NCT03062085 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT03062085 clinical trial?
NCT03062085 is sponsored by Shanghai High Myopia Study Group. The principal investigator is Yi Lu, M.D. at Eye and ENT Hospital of Fudan University. The trial plans to enroll 60,000 participants.